MILabs

MILabs provides high-performance standalone & integrated SPECT, PET, CT and #Opticalimaging systems for #Molecularimaging and #InVivoimaging research.

[MILabs @MILabsBV]

We wish all our relations Happy Holidays and of course a Healthy and Happy 2024!
See you in the new year!

[MILabs @MILabsBV]

Thank you for joining us @ booth 4088 and at the bar during the social event. If you haven't stopped by yet, today is your last chance to meet our crew #SNMMI2023

[MILabs @MILabsBV]

Meet us at AACR annual meeting – the American Association for Cancer Research – AACR 2023, April 14 - 19, and discover our preclinical imaging solutions.

#PET #SPECT #CT #optical #multimodality #molecularimaging #preclinicalimaging #milabs #orlando #AACR2023

[MILabs @MILabsBV]

Meet us at AACR annual meeting – the American Association for Cancer Research – AACR 2023, April 14 - 19, and discover our preclinical imaging solutions.

#PET #SPECT #CT #optical #multimodality #molecularimaging #preclinicalimaging #milabs #orlando #AACR2023

[MILabs @MILabsBV]

Meet us EMIM 2023: European Molecular Imaging Meeting

https://t.co/yC5GPOE0Ny
https://t.co/s16MzVcACQ

[MILabs @MILabsBV]

NEW INSIGHTS INTO KEY MECHANISMS OF siRNA-LNP BIODISTRIBUTION
Publication in Advanced Healthcare Materials:
https://t.co/dqe2An2o6X
Used imaging platform: https://t.co/2K1hsm5FHw

#fluorescencetomography #UCT #3DOI #makingmolecularimagingclear #milabs

[MILabs @MILabsBV]

Meet us at #EMIM2023, March 14-17, and discover our preclinical imaging solutions. In addition, join the #MILabs Lunch Symposium on March 15, starting at 12.15 pm, and learn about exciting features and applications of MILabs imaging systems.
#molecularimaging #preclinicalimaging

[MILabs @MILabsBV]

IDENTIFYING A NEW PATHWAY FOR EFFICIENT DISTRIBUTION OF NANOPARTICLES IN THE BRAIN USING ULTRA HIGH-RESOLUTION SPECT/CT

Publication in Journal of Controlled Release: https://t.co/kXRjI46bs1
Used imaging platform: https://t.co/2K1hsm5FHw

#SPECTCT #drugdelivery #nanoparticles

[MILabs @MILabsBV]

The use of modified bismuth-based mesoporous-silica-coated nanoparticles in #CT #cancerimaging and image-guided synergistic photothermal chemotherapy was investigated. Imaging platform: #MILabs U-CT system.

Publication in Advanced Optical Materials: https://t.co/AQ0CPwH0Jl

[MILabs @MILabsBV]

Influence of different NIRF dyes on the pharmacokinetics, biodistribution and tumor cell uptake of pHPMAs nanocarriers investigated

https://t.co/2XPZOcgQZS

#OI #OI/CT #FLT #fluorescencetomography #makingmolecularimagingclear #milabs #NIRfluorescence #fluorescencedyes

[MILabs @MILabsBV]

New immuno-PET imaging probe developed. [89Zr] was used as a label to investigate in vivo stability, biodistribution, and specific tumor affinity in mice using an MILabs #VECTorCT imaging instrument. https://t.co/4Tam7otCuM

#PET #PETCT #oncology #theranostics #immunoPET #invivo

[MILabs @MILabsBV]

New FAP-targeted radioligand therapy (RLT) comprised of a FAP6 ligand conjugated to DOTA and an albumin-binder developed. Its performance was evaluated #invivo in four different murine #tumor models using an #MILabs #VECTorCT imaging instrument.
https://t.co/jyqnla6Ddh

[MILabs @MILabsBV]

We can’t wait to meet you in Chicago at the #RSNA2022, Saturday-Wednesday, November 27-30. Visit our booth to discuss your imaging needs.
#PET #SPECT #CT #optical #preclinicalimaging #radiotherapy #theranostics #molecularimaging #nuclearimaging #invivo #multimodality #milabs

[MILabs @MILabsBV]

Be sure to stop by the #MILabs booth #78 at the Annual Congress of the European Association of Nuclear Medicine in Barcelona!
We are looking forward to discussing your imaging needs.

#EANM2022 #molecularimaging #preclinicalimaging #event #nuclearmedicine

[MILabs @MILabsBV]

2022 SNMMI MEETING

We can’t wait to finally meet you in person in Vancouver at the #SNMMI meeting. Next to what you can already find in the #MILabs’ SNMMI newsletter we have a lot of news to share. https://t.co/C4Nz43R6SN

#makingimagingclear #molecularimaging

[MILabs @MILabsBV]

JOIN #MILABS’ #SNMMI EVENT

Learn about the latest developments in #MolecularImaging.
Monday, June 13 6:45 am - 7.45 am, Vancouver Convention Centre, West Building, Room 220.

#makingimagingclear #preclinical #theranostics #molecularimaging #multimodalimaging

[MILabs @MILabsBV]

The International Symposium On Radiopharmaceutical Sciences (The ISRS 2022) will take place in Nantes, France, May 29-June 2. We look forward to discussing your imaging needs.
#preclinical #MILabs #radiotherapy #theranostics #molecularimaging #nuclearmedicine #invivo #ISRS2022

[MILabs @MILabsBV]

ULTRA-HIGH-RES CT imaging of drug-induced alveolar bone regeneration was performed by Jinan University, Curtin University, and The University of Western Australia using MILabs’ U-CT.
Read here:

https://t.co/5WBjnm6Qbd

#microCT #bone #periodontitis #tissueengineering #MILabs

[MILabs @MILabsBV]

The German Conference for Nuclear Medicine will take place in Leipzig, Germany, April 27-30. Meet us at #NukMed2022, booth #D2.
#preclinical #preclinicalimaging #makingimagingclear #SPECTCT #MILabs

[MILabs @MILabsBV]

Detailed SPECT/CT imaging of KIDNEY DAMAGE was enabled using a NOVEL RECOMBINANT TRACER

@NorthwesternU and Xi'an Jiaotong University

Read here the PUBLICATION in #THERANOSTICS:
https://t.co/l7xmlzdLTo

#kidney #kidneydisease #MILabs #SPECT #SPECTCT #invivo #mice